Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents. (Q36321399)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

9 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Guillermo Garcia-Manero

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

9 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

9 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

635-642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

The nucleosome: from genomic organization to genomic regulation

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

A tale of histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Histone methylation: dynamic or static?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

The language of covalent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Histones and histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Deciphering the transcriptional histone acetylation code for a human gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Cascade of distinct histone modifications during collagenase gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Sirtuins: Sir2-related NAD-dependent protein deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

The histone deacetylase-3 complex contains nuclear receptor corepressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

A phase I trial of depsipeptide (FR901228) in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Valproic acid toxicity: overview and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Medium chain acyl-CoA dehydrogenase deficiency and fatal valproate toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: time dependence of peroxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Valproic acid hepatic fatalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Valproic acid for the treatment of pediatric malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

DNA methylation in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

DNA methylation in haematological malignancies: the role of decitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

Rhythmic histone acetylation underlies transcription in the mammalian circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07357900500283119

10.1080/07357900500283119

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305991 AND SRC:MED&resulttype=core&format=json

release_rs3w6iuo4jeolm3rxp53evqiqq

9 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rs3w6iuo4jeolm3rxp53evqiqq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference